$0.478
0[0.00%]
At close: Feb 7
Sio Gene Therapies Inc
(OTC:SIOX)Sio Gene Therapies Inc Stock (OTC:SIOX), Analyst Ratings, Price Targets, Predictions
Sio Gene Therapies Inc has a consensus price target of $2.45, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., Cantor Fitzgerald, and HC Wainwright & Co. on April 28, 2022, April 28, 2022, and February 1, 2022. With an average price target of $2.6 between HC Wainwright & Co., Cantor Fitzgerald, and HC Wainwright & Co., there's an implied 443.93% upside for Sio Gene Therapies Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Cantor Fitzgerald
SVB Leerink
BTIG
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Sio Gene Therapies Inc
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/28/2022 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | — | HC Wainwright & Co. | Joseph Pantginis | — | Downgrade | Buy → Sell | Get Alert |
| 04/28/2022 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 67.36% | Cantor Fitzgerald | Kristen Kluska | → $0.8 | Downgrade | Overweight → Neutral | Get Alert |
| 02/01/2022 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 1364.44% | HC Wainwright & Co. | Joseph Pantginis | $10 → $7 | Maintains | Buy | Get Alert |
| 02/01/2022 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 109.21% | SVB Leerink | Mani Foroohar | $6 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 10/21/2021 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 1992.05% | HC Wainwright & Co. | Joseph Pantginis | — | Maintains | Buy | Get Alert |
| 08/12/2021 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 1155.23% | SVB Leerink | Mani Foroohar | — | Maintains | Outperform | Get Alert |
| 06/15/2021 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 1573.64% | BTIG | Yun Zhong | — | Initiates | → Buy | Get Alert |
| 04/30/2021 | SIOX | Buy Now | Sio Gene Therapies | $0.48 | 1573.64% | HC Wainwright & Co. | Joseph Pantginis | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Sio Gene Therapies Inc (SIOX)?
The latest price target for Sio Gene Therapies Inc (OTC: SIOX) was reported by HC Wainwright & Co. on April 28, 2022. The analyst firm set a price target for $0.00 expecting SIOX to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sio Gene Therapies Inc (SIOX)?
The latest analyst rating for Sio Gene Therapies Inc (OTC: SIOX) was provided by HC Wainwright & Co., and Sio Gene Therapies Inc downgraded their sell rating.
When was the last upgrade for Sio Gene Therapies Inc (SIOX)?
There is no last upgrade for Sio Gene Therapies Inc.
When was the last downgrade for Sio Gene Therapies Inc (SIOX)?
The last downgrade for Sio Gene Therapies Inc happened on April 28, 2022 when HC Wainwright & Co. changed their price target from N/A to N/A for Sio Gene Therapies Inc.
When is the next analyst rating going to be posted or updated for Sio Gene Therapies Inc (SIOX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sio Gene Therapies Inc, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sio Gene Therapies Inc was filed on April 28, 2022 so you should expect the next rating to be made available sometime around April 28, 2023.
Is the Analyst Rating Sio Gene Therapies Inc (SIOX) correct?
While ratings are subjective and will change, the latest Sio Gene Therapies Inc (SIOX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Sio Gene Therapies Inc (SIOX) is trading at is $0.48, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.